Hélène Fontaine (H Fontaine)

Publication Activity (10 Years)

Years Active: 2016-2021
Publications (10 Years): 4

Top Topics

Ejection Fraction

Prognostic Factors

Hepatitis B Virus

Newly Diagnosed

Top Venues

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Stanislas Pol, Clovis Luzivika Nzinga, Hélène Fontaine, Fabrice Carrat, null null
Editorial: similar risk of hepatocellular carcinoma in chronic hepatitis B patients treated with tenofovir or entecavir-new clues from Europe. Authors' reply. Alimentary pharmacology & therapeutics 53 (5) (2021)
S Pol, G Haour, Hélène Fontaine, C Dorival, F Carrat, null null
Letter: more studies are needed to elucidate the impact of HBV/HCV coinfection on cirrhosis and its consequences-Authors' reply. Alimentary pharmacology & therapeutics 47 (4) (2019)
S Pol, G Haour, Hélène Fontaine, C Dorival, V Petrov-Sanchez, M Bourliere, J Capeau, P Carrieri, D Larrey, C Larsen, P Marcellin, J-M Pawlostky, Pierre Nahon, F Zoulim, Patrice Cacoub, V de Ledinghen, P Mathurin, F Negro, G-P Pageaux, Y Yazdanpanah, L Wittkop, J-P Zarski, F Carrat, null null
The negative impact of HBV/HCV coinfection on cirrhosis and its consequences. Alimentary pharmacology & therapeutics 46 (11-12) (2017)
Luca Arcaini, Caroline Besson, Marco Frigeni, Hélène Fontaine, Maria Goldaniga, Milvia Casato, Marcella Visentini, Harrys A Torres, Veronique Loustaud-Ratti, Jan Peveling-Oberhag, Paolo Fabris, Roberto Rossotti, Francesco Zaja, Luigi Rigacci, Sara Rattotti, Raffaele Bruno, Michele Merli, Céline Dorival, Laurent Alric, Arnaud Jaccard, Stanislas Pol, Fabrice Carrat, Virginia Valeria Ferretti, Chiara Rusconi, Olivier Hermine
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection. Blood 128 (21) (2016)